Board summary
Key figures
37,006
Registered population
58.9% aged 18–64
23.7%
Aged 65+
ICB 20.0% · England 17.9%
3.9%
Ethnic minority (non-White)
1.8% Asian · England 9.6%
38.3%
In IMD quintile 1
ICB 30.6% · England 21.0%
~11,896
Core20 residents (est.)
Resident basis; registered basis ~13,522 · see page 3
7,716
Hypertension register
+4.88% in 3 yrs · England +5.60%
537
SMI register
17.6% of Blackpool (LAD)'s
1,474
COPD register
Reviews -7.21% in 3 yrs
Forecast to 2030
8,432
Hypertension patients, 2030
+716 on today
64.7%
QRISK ≥20% on statins, 2030
+1.40pp over 3 yrs
6.5%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Annual review coverage fell across key chronic registers.
Over 2023 to 2025, COPD reviews changed by -7.2% (England +2.8%), asthma by -5.1% (England +4.4%) and heart failure by -4.8% (England +8.7%).
SMI physical health checks lag England benchmarks.
Psychosis alcohol recording is 75.6% (England 81.8%), while SMI BMI recording is 76.0% (England 82.1%) and BP recording is 79.2% (England 83.4%).
Diabetes and hypertension control exceed national benchmarks.
Diabetes HbA1c control without frailty is 61.1% (England 57.4%), rising +4.6% over 2023 to 2025, alongside 74.3% hypertension control (England 70.3%).
Population, age and ethnicity
Older age profiles dominate with 23.7% aged 65+ exceeding borough and national averages
Blackpool South PCN has 37,006 registered patients. Older patients dominate the list: 23.7% (8,784 patients) are aged 65+, exceeding Blackpool (20.4%), the ICB (20.0%), and England (17.9%). Children aged 0-17 represent 17.3% (6,413 patients), below Blackpool (18.4%), the ICB (19.6%), and England (19.6%). These age figures reflect registered patients, whereas ethnic composition reflects local Census usual residents: 96.1% are White, above Blackpool (94.7%), the ICB (87.8%), and England (81.1%), with a 3.9% ethnic minority share. This older age profile may increase demand for complex chronic condition management across practices.
Age profile
65+: ICB 20.0%, England 17.9%
Ethnicity
Older people · falls rows are Blackpool (LAD) local-authority (LA) data, not PCN
| Measure | Local | North West | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Blackpool LA) | 1,647 | 2,071 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 82.6% | 82.9% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 61.1% | 56.6% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Blackpool LA) | 955 | 1,021 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Blackpool LA) | 16.9 | 18.2 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 share is 38.3% PCN-wide, varying by 12.1 pp across the four practices
Across Blackpool South PCN, 38.3% of registered patients live in Core20 areas, below Blackpool (55.1%) but above the ICB (30.6%) and England (21.0%). Practice concentration spans a 12.1 pp range from Abbey Dale Medical Centre (29.6%) to Stonyhill Medical Practice (41.6%). Absolute Core20 volume is highest at Stonyhill Medical Practice (4,962 patients) and Highfield Surgery (4,514 patients). A 1.78 percentage point discrepancy between PCN share and weighted practice share (36.5%) requires baseline confirmation. Differentiating concentration from volume ensures outreach reaches both high-density populations and large-list caseloads.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
537
SMI register
1.42% recorded prevalence
232
Learning disability register
0.61% recorded prevalence
27
Care homes, 695 beds
In the PCN catchment
10.9%
Provide unpaid care
Blackpool (LAD), Census 2021
The severe mental illness register records 537 patients (1.4% vs England 1.0%), while learning disability prevalence is 0.6% (232 patients; England 0.6%). Catchment services cover 27 care homes with 695 beds. Borough data records 11 rough sleepers in an autumn 2025 snapshot and a Census unpaid care rate giving an unverified PCN ceiling of 4,034 carers.
Severe mental illness: physical health checks
Recorded checks on 537 SMI patients (1.4% vs England 1.0%) trail England for blood pressure (79.2% vs 83.4%), BMI (76.0% vs 82.1%) and alcohol (75.6% vs 81.8%), though each check exceeds Blackpool (LAD).
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
7,716
Hypertension register
+4.88%
Register growth, 3 yrs
Blackpool (LAD) +5.85% · England +5.60%
−0.71pp
BP control, under 80
≤140/90 · −3.14pp aged 80+
+716
More patients by 2030
Forecast 8,432 (22.47%)
Hypertension case-finding and control
The hypertension register includes 7,716 patients, representing 20.4% recorded prevalence against 19.4% in Blackpool (LAD), 17.2% in the ICB and 15.2% in England. Current control snapshots exceed benchmarks: 74.3% of hypertensive patients are treated to target (England 70.3%) and 84.5% aged 80+ meet blood pressure thresholds (England 81.2%). However, three-year trajectories show control slipping: treatment to target fell 1.8% over 2023 to 2025 while England rose +3.6%, and 80+ control dropped 3.6% while England rose +2.2%. Observation periods are unstated and control denominators include personalised care adjustments. Falling blood pressure control across an above-average recorded burden indicates that re-establishing systematic annual clinical reviews could protect intermediate outcomes.
Lipids and statins
For patients with QRISK ≥ 20%, lipid-lowering therapy coverage is 61.8%, below England (63.6%) and Blackpool (LAD) (62.5%), though slightly above the ICB (61.4%). PCN coverage grew +2.3% over 2023 to 2025, lagging England (+6.2%).
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 112,827 | £1.70 | £1.64 | £1.86 | £191,806 |
| Cardiovascular (all), 2025 | 159,702 | £3.15 | £3.38 | £3.33 | £503,061 |
For lipid-regulating drugs in 2026, 112,827 items cost £1.70 per item (spend £191,806), compared with £1.86 in England, £1.49 in Blackpool (LAD) and £1.64 in the ICB. The PCN spends £18,052 less than at England's unit cost, but £6,770 more than at the ICB's unit cost across 112,827 items.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
−5.09%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+2.81%
Asthma prevalence, PCN 3-yr % change
COPD prevalence is 3.9% (1,474 patients; England 1.9%) and asthma is 8.2% (2,938 patients; England 6.6%). Over 2023 to 2025, 12-month reviews fell 7.2% for COPD to 76.7% (England +2.8%) and fell 5.1% for asthma to 64.8% (England +4.4%), leaving about 1,000 asthma patients without a recorded review. Asthma prescribing for ages 5-19 reached 2,443 items per 1,000 (England 1,488). Slower review delivery alongside high youth prescribing may reflect clinical capacity constraints, which practice workload audit would test.
Cancer register and children's immunisation
The cancer register comprises 1,989 patients (5.3% vs England 3.8%). In Q1 2025/26 childhood immunisations, 12-month 6-in-1 coverage was 85.2% (England 91.0%), sitting below the 95.0% target by 9.8 pp. At age 5, second-dose MMR was 85.1% (a 4.6 pp drop from dose 1 at 89.7%) and 4-in-1 booster coverage was 82.8%, trailing the 95.0% target by 12.2 pp, consistent with pre-school recall attrition that practice audits would test.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
52.4%
Lancashire and South Cumbria ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~2,010
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Lancashire and South Cumbria ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Breast | 86.0% | 85.4% | 6% | 1,561 |
| Prostate | 42.4% | 53.2% | 11% | 1,404 |
| Lung | 31.1% | 33.8% | 15% | 1,374 |
| Bowel | 44.2% | 47.0% | 13% | 1,198 |
| Skin cancer | 86.1% | 87.8% | 21% | 519 |
In 2022, 52.4% of cancers with a known stage (4,642 of 8,863) were diagnosed at stage 1 or 2 across NHS Lancashire and South Cumbria ICB, trailing England (55.3%) and 22.6 pp below the 75.0% national ambition by 2028, requiring about 2,010 extra early-stage diagnoses. Known-stage completeness was 74.6% (8,863 of 11,883 registered cancers), and ICB early-stage share fell 1.2 pp from 53.6% in 2013. Staging data reflects ICB boundaries rather than PCN performance. PCN cervical screening coverage was 68.8% after falling 3.5% over 2023 to 2025 (England -1.0%), led by Highfield Surgery falling 7.1% to 66.0%.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In Jul 2026 (provisional), Blackpool Teaching Hospitals NHS Foundation Trust achieved 67.5% on the 62-day referral to treatment standard, 17.5 pp below the 85.0% standard and trailing England (71.2%), the ICB (73.6%), and Lancashire Teaching Hospitals (75.0%). On the 28-day faster diagnosis standard, the trust achieved 71.4%, 3.6 pp below the 75.0% standard (ICB 78.4%; England 79.3%). For diagnostics, 21.8% of patients waited 6+ weeks for MRI (England 21.4%) and 27.6% for non-obstetric ultrasound (England 19.6%). These provider figures describe acute trust pressure rather than PCN performance.
| Pathways within standard (%) | Blackpool | Lancashire | of Morecambe Bay | Lancashire and South Cumbria ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 71.38 | 82.90 | 78.39 | 78.39 | 79.32 |
| 31-day treatment (96%) | 97.96 | 89.43 | 95.22 | 93.62 | 92.50 |
| 62-day referral to treatment (85%) | 67.48 | 75.04 | 72.35 | 73.62 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Blackpool | Lancashire | of Morecambe Bay | England |
|---|---|---|---|---|
| MRI | 21.80 | 2.41 | 4.04 | 21.40 |
| CT | 16.49 | 14.97 | 13.76 | 9.92 |
| Echocardiography | 7.57 | 13.85 | 10.55 | 28.48 |
| Colonoscopy | 13.08 | 0.00 | 0.60 | 30.83 |
| Gastroscopy | 12.47 | 0.00 | 1.45 | 29.02 |
| All 15 DM01 tests | 26.54 | 26.65 | 10.44 | 23.14 |
| Community services activity | Blackpool residents | Lancashire and South Cumbria ICB |
|---|---|---|
| Care contacts | 28,770 | 193,720 |
| Referrals | 4,700 | 29,855 |
| Patients with a contact | 8,925 | 65,335 |
Community services (residents of Blackpool), Jun 2026 (provisional). In Jun 2026 (provisional), community health service contacts for Blackpool residents totalled 28,770, with 16,710 contacts involving adults aged 65 and over (58.1% of all contacts). These borough-level figures capture resident activity across Blackpool rather than PCN-specific referrals, illustrating the volume of older adult community care delivered across the local health economy.
Practice variation and patient experience
Vaccination domain achievement varies by 22.4 pp across member practices
In 2025/26, QOF clinical domain achievement ranged from 92.9% at Arnold Medical Centre to 100.0% at Highfield Surgery. In the vaccination and immunisation domain, achievement varied by 22.4 pp, from 27.8% at Highfield Surgery to 50.2% at Arnold Medical Centre (England 55.2%). Domain achievement reflects awarded points rather than direct population coverage.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Arnold | 123 | 38.5 | 94.0% | 68.1% | 89.8% |
| Abbey Dale | 99 | 29.6 | 78.1% | 75.0% | 86.2% |
| Stonyhill Medical | 109 | 41.6 | 65.2% | 76.1% | 81.0% |
| Highfield Surgery | 114 | 34.1 | 71.3% | 74.2% | 75.7% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Eighteen of 25 measures trail England's three-year change, led by chronic disease reviews
Over 2023 to 2025, 18 of 25 tracked measures trail England's change. The widest relative three-year review lags are heart failure (-4.8% vs England +8.7%), COPD (-7.2% vs England +2.8%), and asthma (-5.1% vs England +4.4%). Relative strengths include breast screening coverage at +14.0% over 2023 to 2024 (England +8.4%), and diabetes HbA1c control without frailty at +4.6% (England +4.4%) with current achievement at 61.1% (England 57.4%). Trailing review trends may leave expanding disease cohorts unmonitored despite strong intermediate control.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Heart failure reviews
COPD reviews
Asthma reviews
Alcohol record (psychosis)
BP control, 80+
Breast screening (53-70)
Diabetes HbA1c control
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Blackpool (LAD) | Asset | PCN | Blackpool (LAD) |
|---|---|---|---|---|---|
| Care homes (catchment) | 27 (695 beds) | n/a | Schools (catchment) | 36 | n/a |
| Children's centres | 3 | 13 | Places of worship | 24 | 62 |
| Libraries | 1 | 8 | Food banks (VCS) | n/a | 1 |
| Children and young people (VCS) | n/a | 1 | Primary schools (LA maintained) | 1 | 5 |
| Primary academies | 11 | 26 | Special schools | n/a | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Structured asthma review recall
Asthma review coverage is 64.8% (England 65.7%; ICB 65.0%), falling 5.1% (3.5 pp) over 2023 to 2025 (England +4.4%, +2.8 pp), leaving 1,033 (about 1,000) of 2,938 patients unreviewed. For discussion: practices could run template-driven recall, flexible after-school slots, and inhaler prescribing reviews for unreviewed patients. Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Pre-school booster catch-up recall
In Q1 2025/26, age-5 4-in-1 coverage is 82.8% (below the 95.0% target by 12.2 pp; ICB 85.2%, England 80.9%) and MMR2 is 85.1% (below by 9.9 pp), with a 22.4 pp QOF vaccination range. Moderate effort to run.
Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.
Policy anchor: 10 Year Health Plan, shift from sickness to prevention.
Option 3
Combined SMI physical health checks
Across 537 SMI patients (17.6% of borough register), checks trail England for alcohol (75.6% vs 81.8%), BMI (76.0% vs 82.1%) and BP (79.2% vs 83.4%); patient gap is not sized. For discussion: practices could offer combined single-appointment SMI checks, review templates for partial checks, and liaise with mental health partners. Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Older population care coordination (p2) | Aged 65+ | Neighbourhood health framework · NHS vaccination strategy | PCN |
| Two-track Core20 outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI physical health recall (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension blood pressure recall audit (p5) | Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school immunisation catch-up (p6) | 4-in-1 pre-school booster (DTaP/IPV) coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall audit (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Option 1 · Structured asthma review recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 Population | Core20PLUS5 respiratory | PCN |
| Option 2 · Pre-school booster catch-up recall (p12) | 4-in-1 pre-school booster (DTaP/IPV) coverage at age 5 · MMR dose 2 coverage at age 5 · 6-in-1 coverage at 12 months | 10YHP sickness to prevention · 95% target | PCN |
| Option 3 · Combined SMI physical health checks (p12) | Severe mental illness register · Patients with psychosis who have a current record of alcohol consumption · SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | Local authority | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
